论文信息 - Update of a Phase I Study of Sorafenib in Patients with Refractory/Relapsed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome. - 字舞流文

Update of a Phase I Study of Sorafenib in Patients with Refractory/Relapsed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome.

M. Konopleva | M. Andreeff | H. Kantarjian | J. Cortes | S. Verstovsek | F. Ravandi | G. Borthakur | Weiguo Zhang | J. Wright | S. Faderl | J. Delmonte